Amol Akhade/hiranandanihospital.org
Jan 9, 2025, 03:44
Amol Akhade: Mariposa shows significant OS benifit
Amol Akhade, A Senior Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals shared a post on LinkedIn:
“Mariposa shows significant OS benifit .
Median OS Improved by more than one year.
Press release.
Considering toxicity of Amivantamab plus Lazertinib, now with OS data, will u change the practice?
It will be intresting to see final data once presented.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 22:57
Aug 6, 2025, 22:41
Aug 6, 2025, 22:14
Aug 6, 2025, 21:48
Aug 6, 2025, 21:33
Aug 6, 2025, 21:22
Aug 6, 2025, 21:13